SCOPUS 정보 검색 플랫폼

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 5, 2010, Pages 814-816

Temporal changes in the use of blood products for coronary artery bypass graft surgery in North America: An analysis of the society of thoracic surgeons adult cardiac database

(7) Bennett Guerrero, Elliott a Song, Howard K b Zhao, Yue a Ferguson Jr , T B c Gammie, James S d Peterson, Eric D a O'Brien, Sean M a

a DUKE CLINICAL RESEARCH INSTITUTE (United States)

b OREGON HEALTH AND SCIENCE UNIVERSITY (United States)

c East Carolina Heart Institute (United States)

d UNIVERSITY OF MARYLAND MEDICAL CENTER (United States)

Author keywords

blood; cardiopulmonary bypass; coronary artery bypass graft surgery; red blood cell; transfusion

Indexed keywords

APROTININ;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS SURGERY; DATA BASE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; PLASMA TRANSFUSION; PRIORITY JOURNAL; THORAX SURGERY; THROMBOCYTE TRANSFUSION;

EID: 77957693973 PISSN: 10530770 EISSN: None Source Type: Journal
DOI: 10.1053/j.jvca.2010.06.003 Document Type: Review

Times cited : (9)

References (7)

1
- 34247269097
- Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline
- V.A. Ferraris, S.P. Ferraris, and S.P. Saha Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 83 suppl 2007 S27 S86
- (2007) Ann Thorac Surg , vol.83 , Issue.SUPPL.
- Ferraris, V.A.¹ Ferraris, S.P.² Saha, S.P.³

2
- 84856617809
- B.H. Pharmaceuticals Bayer Temporarily Suspends Global Trasylol Marketing http://www.trasylol.com/Trasylol-11-05-07.pdf Accessed August 13, 2009
- Bayer Temporarily Suspends Global Trasylol Marketing
- Pharmaceuticals, B.H.¹

3
- 33846885901
- Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery
- D.T. Mangano, Y. Miao, and A. Vuylsteke Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery JAMA 297 2007 471 479
- (2007) JAMA , vol.297 , pp. 471-479
- Mangano, D.T.¹ Miao, Y.² Vuylsteke, A.³

4
- 31344467254
- The risk associated with aprotinin in cardiac surgery
- D.T. Mangano, I.C. Tudor, and C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365
- (2006) N Engl J Med , vol.354 , pp. 353-365
- Mangano, D.T.¹ Tudor, I.C.² Dietzel, C.³

5
- 39549099909
- The effect of aprotinin on outcome after coronary artery bypass grafting
- A.D. Shaw, M. Stafford-Smith, and W.D. White The effect of aprotinin on outcome after coronary artery bypass grafting N Engl J Med 358 2008 784 793
- (2008) N Engl J Med , vol.358 , pp. 784-793
- Shaw, A.D.¹ Stafford-Smith, M.² White, W.D.³

6
- 44349089188
- A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
- D.A. Fergusson, P.C. Hebert, and C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331
- (2008) N Engl J Med , vol.358 , pp. 2319-2331
- Fergusson, D.A.¹ Hebert, P.C.² Mazer, C.D.³

7
- 0347933059
- Procedural volume as a marker of quality for CABG surgery
- E.D. Peterson, L.P. Coombs, and E.R. DeLong Procedural volume as a marker of quality for CABG surgery JAMA 291 2004 195 201
- (2004) JAMA , vol.291 , pp. 195-201
- Peterson, E.D.¹ Coombs, L.P.² Delong, E.R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.